Real-time enrollment status for this type 1 diabetes clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 11:28 AM UTC
| NCT Number | NCT07187531 |
| Recruiting Status | Recruiting |
| Condition | Type 1 Diabetes |
| Phase | PHASE2 |
| Target Enrollment | 159 participants |
| Active Locations | 23 sites in the US |
| Sponsor | SAb Biotherapeutics, Inc. |
| Last Updated on CT.gov | August 24, 2026 (3 days ago) |
As of August 27, 2026: Clinical trial NCT07187531 is currently recruiting participants. This phase2 study for type 1 diabetes is actively seeking new participants at 23 locations across the United States. The study is sponsored by SAb Biotherapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07187531 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07187531 was last updated 3 days ago (August 24, 2026). HelloStudys verifies this status automatically.